Adrenergic beta-Agonists

"Adrenergic beta-Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that selectively bind to and activate beta-adrenergic receptors.

Descriptor ID	D000318
MeSH Number(s)	D27.505.519.625.050.100.200 D27.505.696.577.050.100.200
Concept/Terms	Adrenergic beta-Agonists Adrenergic beta-Agonists Adrenergic beta Agonists beta-Agonists, Adrenergic Adrenergic beta-Receptor Agonist Adrenergic beta Receptor Agonist Agonist, Adrenergic beta-Receptor beta-Receptor Agonist, Adrenergic Adrenergic beta-Receptor Agonists Adrenergic beta Receptor Agonists Agonists, Adrenergic beta-Receptor beta-Receptor Agonists, Adrenergic beta-Adrenergic Agonist Agonist, beta-Adrenergic beta Adrenergic Agonist Receptors Agonists, Adrenergic beta beta-Adrenergic Receptor Agonist Agonist, beta-Adrenergic Receptor Receptor Agonist, beta-Adrenergic beta Adrenergic Receptor Agonist beta-Adrenergic Receptor Agonists Agonists, beta-Adrenergic Receptor beta Adrenergic Receptor Agonists Betamimetics Receptor Agonists, beta-Adrenergic Receptor Agonists, beta Adrenergic Adrenergic beta-Agonist Adrenergic beta Agonist beta-Agonist, Adrenergic beta-Adrenergic Agonists Agonists, beta-Adrenergic beta Adrenergic Agonists

Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-Agonists".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Neurotransmitter Agents [D27.505.519.625]
Adrenergic Agents [D27.505.519.625.050]
Adrenergic Agonists [D27.505.519.625.050.100]
Adrenergic beta-Agonists [D27.505.519.625.050.100.200]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
Adrenergic Agents [D27.505.696.577.050]
Adrenergic Agonists [D27.505.696.577.050.100]
Adrenergic beta-Agonists [D27.505.696.577.050.100.200]

Below are MeSH descriptors whose meaning is related to "Adrenergic beta-Agonists".

Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-Agonists".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Adrenergic beta-Agonists" by people in this website by year, and whether "Adrenergic beta-Agonists" was a major or minor topic of these publications.

Bar chart showing 50 publications over 20 distinct years, with a maximum of 6 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1995	0	1	1
1996	0	1	1
1997	0	1	1
2002	1	1	2
2003	2	3	5
2004	3	3	6
2005	1	1	2
2006	4	0	4
2007	4	1	5
2008	2	2	4
2009	1	3	4
2010	2	0	2
2011	0	5	5
2012	0	2	2
2014	1	0	1
2015	1	0	1
2016	0	1	1
2018	0	1	1
2021	1	0	1

Below are the most recent publications written about "Adrenergic beta-Agonists" by people in Profiles.

Nayak AP, Lim JM, Arbel E, Wang R, Villalba DR, Nguyen TL, Schaible N, Krishnan R, Tang DD, Penn RB. Cooperativity between ß-agonists and c-Abl inhibitors in regulating airway smooth muscle relaxation. FASEB J. 2021 07; 35(7):e21674.

View in: PubMed
Lasa JJ, Jain P, Raymond TT, Minard CG, Topjian A, Nadkarni V, Gaies M, Bembea M, Checchia PA, Shekerdemian LS, Thiagarajan R. Extracorporeal Cardiopulmonary Resuscitation in the Pediatric Cardiac Population: In Search of a Standard of Care. Pediatr Crit Care Med. 2018 02; 19(2):125-130.

View in: PubMed
Foglia EE, Langeveld R, Heimall L, Deveney A, Ades A, Jensen EA, Nadkarni VM. Incidence, characteristics, and survival following cardiopulmonary resuscitation in the quaternary neonatal intensive care unit. Resuscitation. 2017 01; 110:32-36.

View in: PubMed
Andersen LW, Berg KM, Saindon BZ, Massaro JM, Raymond TT, Berg RA, Nadkarni VM, Donnino MW. Time to Epinephrine and Survival After Pediatric In-Hospital Cardiac Arrest. JAMA. 2015 Aug 25; 314(8):802-10.

View in: PubMed
Grisanti LA, Repas AA, Talarico JA, Gold JI, Carter RL, Koch WJ, Tilley DG. Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic ?-adrenergic receptor stimulation. Am J Physiol Heart Circ Physiol. 2015 Feb 15; 308(4):H316-30.

View in: PubMed
Lewis AM, Aley PK, Roomi A, Thomas JM, Masgrau R, Garnham C, Shipman K, Paramore C, Bloor-Young D, Sanders LE, Terrar DA, Galione A, Churchill GC. ?-Adrenergic receptor signaling increases NAADP and cADPR levels in the heart. Biochem Biophys Res Commun. 2012 Oct 19; 427(2):326-9.

View in: PubMed
Singh J, Rattan S. Bioengineered human IAS reconstructs with functional and molecular properties similar to intact IAS. Am J Physiol Gastrointest Liver Physiol. 2012 Sep 15; 303(6):G713-22.

View in: PubMed
Katz MG, Fargnoli AS, Swain JD, Tomasulo CE, Ciccarelli M, Huang ZM, Rabinowitz JE, Bridges CR. AAV6-?ARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve. J Thorac Cardiovasc Surg. 2012 Mar; 143(3):720-726.e3.

View in: PubMed
Minoura Y, Di Diego JM, Barajas-Mart?nez H, Zygmunt AC, Hu D, Sicouri S, Antzelevitch C. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants. J Cardiovasc Electrophysiol. 2012 Apr; 23(4):423-32.

View in: PubMed
Sicouri S, Pourrier M, Gibson JK, Lynch JJ, Antzelevitch C. Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations. Heart Rhythm. 2012 Mar; 9(3):422-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement